Genmab A/S Sustainability Reports

Genmab A/S is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics. The company primarily targets the treatment of cancer and other serious diseases using next-generation antibody technologies.

Sector: Professional & technical services

Country: Denmark

Exchange: Nasdaq Copenhagen

LEI: 529900MTJPDPE4MHJ122

FIGI: BBG001SCV1W8

25 reports from 2007 to 2025

• Genmab A/S 2025 Annual Report
• Genmab A/S 2025 Statutory Corporate Governance Report
• Genmab A/S 2024 Statutory Corporate Governance Report
• Genmab A/S 2024 Annual Report on Form 20-F
• Genmab A/S 2024 Annual Report